18 h. ago InnoCare Announces Approval of Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China

BEIJING, Dec. 17, 2025 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New Drug (IND) by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) to conduct a Phase […]

Transport

21 h. ago Lorne Gunter: Answer the bell — AHS should reinstate ceremony marking successful cancer treatment

Bell ringing when leaving a cancer ward at the end of successful treatment is not specifically a Christmas tradition. However, it’s hard to think of a more Grinch-y action than AHS’s decision to stop the tradition for young cancer patients at Edmonton’s Stollery Children’s Hospital. And to stop the practice with a letter left casually […]

Events

4 d. ago InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the phase IIb clinical study of novel BTK inhibitor orelabrutinib has met the primary endpoint in patients with systemic lupus erythematosus (SLE). InnoCare has also received […]

Politics

6 d. ago GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) — Equity-Insider.com News Commentary – The FDA approved the first perioperative immunotherapy for early gastric and gastroesophageal junction cancers last month, ushering in a new clinical paradigm for patients with historically resistant tumors [1]. Separately, the agency fast-tracked an experimental […]

Economics

6 d. ago King Charles III to give televised address about his cancer treatment

Charles’ decision to disclose his diagnosis was a departure for Britain’s royals, who have traditionally shared few details about their health with the public.

Economics

7 d. ago London hospital embraces use of cancer treatment – for heart ailment

London Health Sciences Centre has become one of the few hospitals in Canada to provide a treatment typically used in cancer care to treat a patient’s heart condition.

Science